{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:01:43Z","timestamp":1780304503748,"version":"3.54.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03168-4","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:00:43Z","timestamp":1777273243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploration of the mechanism by which Ubiquitin-like protein UBD promotes malignant progression of breast cancer"],"prefix":"10.1007","volume":"43","author":[{"given":"Lei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"1","key":"3168_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, et al. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3168_CR2","doi-asserted-by":"publisher","DOI":"10.34133\/research.0854","volume":"8","author":"J Zhang","year":"2025","unstructured":"Zhang J, Huang Z, et al. PRMT1-mediated PARP1 methylation drives lung metastasis and chemoresistance via P65 activation in triple-negative breast cancer. Research. 2025;8:0854.","journal-title":"Research"},{"key":"3168_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102569","author":"B Smolarz","year":"2022","unstructured":"Smolarz B, Nowak AZ, et al. Breast cancer-epidemiology, classification, pathogenesis and treatment (review of literature). Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14102569.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3168_CR4","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3168_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3168_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"3168_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun. 2021;41(11):1183\u201394.","journal-title":"Cancer Commun"},{"issue":"6039","key":"3168_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/bmj.2.6039.781","volume":"2","author":"W Duncan","year":"1976","unstructured":"Duncan W, Kerr GR. The curability of breast cancer. Br Med J. 1976;2(6039):781\u20133.","journal-title":"Br Med J"},{"issue":"5","key":"3168_CR9","first-page":"363","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller KD, Nogueira L, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363\u201385.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3168_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF02660056","volume":"44","author":"W Fan","year":"1996","unstructured":"Fan W, Cai W, et al. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics. 1996;44(2):97\u2013103.","journal-title":"Immunogenetics"},{"key":"3168_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.biocel.2016.07.001","volume":"79","author":"A Aichem","year":"2016","unstructured":"Aichem A, Groettrup M. The ubiquitin-like modifier FAT10 in cancer development. Int J Biochem Cell Biol. 2016;79:451\u201361.","journal-title":"Int J Biochem Cell Biol"},{"issue":"14","key":"3168_CR12","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00018-012-0933-5","volume":"69","author":"F Ebstein","year":"2012","unstructured":"Ebstein F, Lehmann A, et al. The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation. Cell Mol Life Sci. 2012;69(14):2443\u201354.","journal-title":"Cell Mol Life Sci"},{"key":"3168_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060951","author":"MM Mah","year":"2020","unstructured":"Mah MM, Roverato N, et al. Regulation of interferon induction by the ubiquitin-like modifier FAT10. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10060951.","journal-title":"Biomolecules"},{"issue":"6","key":"3168_CR14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Fu L. The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment. Acta Pharm Sin B. 2021;11(6):1400\u201311.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"3168_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/14760584.2018.1541743","volume":"17","author":"JL Tanyi","year":"2018","unstructured":"Tanyi JL, George E. Personalized vaccination against ovarian cancer: what are the possibilities? Expert Rev Vaccines. 2018;17(11):955\u20138.","journal-title":"Expert Rev Vaccines"},{"issue":"49","key":"3168_CR16","doi-asserted-by":"publisher","first-page":"E5282","DOI":"10.1073\/pnas.1403383111","volume":"111","author":"SS Theng","year":"2014","unstructured":"Theng SS, Wang W, et al. Disruption of FAT10-MAD2 binding inhibits tumor progression. Proc Natl Acad Sci U S A. 2014;111(49):E5282-5291.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3168_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2013.02.007","volume":"152","author":"Y Merbl","year":"2013","unstructured":"Merbl Y, Refour P, et al. Profiling of ubiquitin-like modifications reveals features of mitotic control. Cell. 2013;152(5):1160\u201372.","journal-title":"Cell"},{"key":"3168_CR18","first-page":"1643","volume":"8","author":"T Han","year":"2015","unstructured":"Han T, Liu Z, et al. High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer. Onco Targets Ther. 2015;8:1643\u20139.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"3168_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s11427-023-2460-0","volume":"67","author":"X Chen","year":"2024","unstructured":"Chen X, Wu W, et al. Cytokines-activated nuclear IKK\u03b1-FAT10 pathway induces breast cancer tamoxifen-resistance. Sci China Life Sci. 2024;67(7):1413\u201326.","journal-title":"Sci China Life Sci"},{"key":"3168_CR20","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.2147\/OTT.S98410","volume":"9","author":"F Xue","year":"2016","unstructured":"Xue F, Zhu L, et al. FAT10 is associated with the malignancy and drug resistance of non-small-cell lung cancer. Onco Targets Ther. 2016;9:4397\u2013409.","journal-title":"Onco Targets Ther"},{"issue":"46","key":"3168_CR21","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1038\/onc.2008.201","volume":"27","author":"S Lukasiak","year":"2008","unstructured":"Lukasiak S, Schiller C, et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene. 2008;27(46):6068\u201374.","journal-title":"Oncogene"},{"issue":"7","key":"3168_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/onc.2013.236","volume":"33","author":"L Liu","year":"2014","unstructured":"Liu L, Dong Z, et al. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt\/GSK3\u03b2 pathway. Oncogene. 2014;33(7):909\u201320.","journal-title":"Oncogene"},{"issue":"18","key":"3168_CR23","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-14-0284","volume":"74","author":"R Yuan","year":"2014","unstructured":"Yuan R, Wang K, et al. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying \u03b2-catenin degradation. Cancer Res. 2014;74(18):5287\u2013300.","journal-title":"Cancer Res"},{"issue":"1","key":"3168_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12032-023-02259-4","volume":"41","author":"I Akrida","year":"2023","unstructured":"Akrida I, Mulita F, et al. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors. Med Oncol. 2023;41(1):20.","journal-title":"Med Oncol"},{"issue":"6","key":"3168_CR25","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420\u20138.","journal-title":"J Clin Invest"},{"issue":"7702","key":"3168_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, et al. Identification of the tumour transition States occurring during EMT. Nature. 2018;556(7702):463\u20138.","journal-title":"Nature"},{"issue":"3","key":"3168_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.radonc.2011.05.066","volume":"99","author":"MM Nijkamp","year":"2011","unstructured":"Nijkamp MM, Span PN, et al. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011;99(3):344\u20138.","journal-title":"Radiother Oncol"},{"issue":"2","key":"3168_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/modpathol.3800528","volume":"19","author":"CA Livasy","year":"2006","unstructured":"Livasy CA, Karaca G, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19(2):264\u201371.","journal-title":"Mod Pathol"},{"key":"3168_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5050051","author":"AD Grigore","year":"2016","unstructured":"Grigore AD, Jolly MK, et al. Tumor Budding: The Name is EMT. Partial EMT. J Clin Med. 2016. https:\/\/doi.org\/10.3390\/jcm5050051.","journal-title":"J Clin Med"},{"issue":"2","key":"3168_CR30","doi-asserted-by":"publisher","first-page":"e0172559","DOI":"10.1371\/journal.pone.0172559","volume":"12","author":"C Dmello","year":"2017","unstructured":"Dmello C, Sawant S, et al. Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients. PLoS One. 2017;12(2):e0172559.","journal-title":"PLoS One"},{"issue":"1","key":"3168_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s12885-018-4640-y","volume":"18","author":"M Zacharias","year":"2018","unstructured":"Zacharias M, Brcic L, et al. Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated. BMC Cancer. 2018;18(1):717.","journal-title":"BMC Cancer"},{"issue":"22","key":"3168_CR32","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1158\/0008-5472.CAN-16-3521","volume":"77","author":"JT George","year":"2017","unstructured":"George JT, Jolly MK, et al. Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Res. 2017;77(22):6415\u201328.","journal-title":"Cancer Res"},{"issue":"Pt 2","key":"3168_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel M, Serrels A, et al. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013;126(Pt 2):393\u2013401.","journal-title":"J Cell Sci"},{"issue":"1","key":"3168_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbrc.2007.06.036","volume":"360","author":"L McInroy","year":"2007","unstructured":"McInroy L, M\u00e4\u00e4tt\u00e4 A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun. 2007;360(1):109\u201314.","journal-title":"Biochem Biophys Res Commun"},{"key":"3168_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395\u2013412.","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"3168_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41580-024-00733-z","volume":"25","author":"KK Youssef","year":"2024","unstructured":"Youssef KK, Nieto MA. Epithelial-mesenchymal transition in tissue repair and degeneration. Nat Rev Mol Cell Biol. 2024;25(9):720\u201339.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"3168_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70404","volume":"6","author":"MA Samad","year":"2025","unstructured":"Samad MA, Ahmad I, et al. Breast cancer: molecular pathogenesis and targeted therapy. MedComm. 2025;6(10):e70404.","journal-title":"MedComm"},{"key":"3168_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102861","volume":"132","author":"C Hao","year":"2025","unstructured":"Hao C, Wei Y, et al. PI3K\/AKT\/mTOR inhibitors for hormone receptor-positive advanced breast cancer. Cancer Treat Rev. 2025;132:102861.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"3168_CR39","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/S1470-2045(23)00676-9","volume":"25","author":"IM Browne","year":"2024","unstructured":"Browne IM, Andr\u00e9 F, et al. Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer. Lancet Oncol. 2024;25(4):e139\u201351.","journal-title":"Lancet Oncol"},{"issue":"9","key":"3168_CR40","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.18632\/aging.103117","volume":"12","author":"Z Ma","year":"2020","unstructured":"Ma Z, Lou S, et al. PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K\/AKT signaling pathway. Aging. 2020;12(9):7985\u20138000.","journal-title":"Aging"},{"key":"3168_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cytogfr.2025.05.007","volume":"84","author":"Z Ansari","year":"2025","unstructured":"Ansari Z, Chaurasia A, et al. Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression. Cytokine Growth Factor Rev. 2025;84:120\u201334.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"3168_CR42","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/med.21948","volume":"43","author":"HL Ang","year":"2023","unstructured":"Ang HL, Mohan CD, et al. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Med Res Rev. 2023;43(4):1141\u2013200.","journal-title":"Med Res Rev"},{"issue":"1","key":"3168_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12964-023-01225-x","volume":"21","author":"A Maharati","year":"2023","unstructured":"Maharati A, Moghbeli M. PI3K\/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell Commun Signal. 2023;21(1):201.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3168_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13046-024-03118-4","volume":"43","author":"F Gao","year":"2024","unstructured":"Gao F, Liu S, et al. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110\u03b1 mediated activation of AKT signaling pathway. J Exp Clin Cancer Res. 2024;43(1):201.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3168_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-022-03370-2","volume":"20","author":"X Jin","year":"2022","unstructured":"Jin X, Wang D, et al. TPI1 activates the PI3K\/AKT\/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5. J Transl Med. 2022;20(1):191.","journal-title":"J Transl Med"},{"issue":"8","key":"3168_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0962-8924(00)01785-2","volume":"10","author":"S Jentsch","year":"2000","unstructured":"Jentsch S, Pyrowolakis G. Ubiquitin and its kin: how close are the family ties? Trends Cell Biol. 2000;10(8):335\u201342.","journal-title":"Trends Cell Biol"},{"issue":"19","key":"3168_CR47","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1038\/sj.emboj.7600808","volume":"24","author":"K Haglund","year":"2005","unstructured":"Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005;24(19):3353\u20139.","journal-title":"EMBO J"},{"key":"3168_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jare.2023.06.006","volume":"59","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Che B, et al. The ubiquitin-like protein FAT10 in hepatocellular carcinoma cells limits the efficacy of anti-VEGF therapy. J Adv Res. 2024;59:97\u2013109.","journal-title":"J Adv Res"},{"issue":"12","key":"3168_CR49","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y","volume":"29","author":"S Raasi","year":"1999","unstructured":"Raasi S, Schmidtke G, et al. A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol. 1999;29(12):4030\u20136.","journal-title":"Eur J Immunol"},{"issue":"9","key":"3168_CR50","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.4049\/jimmunol.1500592","volume":"195","author":"S Buerger","year":"2015","unstructured":"Buerger S, Herrmann VL, et al. The ubiquitin-like modifier FAT10 is selectively expressed in medullary thymic epithelial cells and modifies T cell selection. J Immunol. 2015;195(9):4106\u201316.","journal-title":"J Immunol"},{"issue":"17","key":"3168_CR51","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/sj.onc.1206337","volume":"22","author":"CG Lee","year":"2003","unstructured":"Lee CG, Ren J, et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene. 2003;22(17):2592\u2013603.","journal-title":"Oncogene"},{"issue":"4","key":"3168_CR52","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12253-012-9511-2","volume":"18","author":"J Yuan","year":"2012","unstructured":"Yuan J, Tu Y, et al. Increased expression of FAT10 is correlated with progression and prognosis of human glioma. Pathol Oncol Res. 2012;18(4):833\u20139.","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"3168_CR53","first-page":"2066","volume":"10","author":"X Deng","year":"2020","unstructured":"Deng X, Deng J, et al. Ubiquitin-like protein FAT10 promotes osteosarcoma Glycolysis and growth by upregulating PFKFB3 via stabilization of EGFR. Am J Cancer Res. 2020;10(7):2066\u201382.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3168_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112401","volume":"398","author":"Y Zou","year":"2021","unstructured":"Zou Y, Du Y, et al. FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR\/AKT pathway. Exp Cell Res. 2021;398(1):112401.","journal-title":"Exp Cell Res"},{"issue":"49","key":"3168_CR55","doi-asserted-by":"publisher","first-page":"81463","DOI":"10.18632\/oncotarget.12976","volume":"7","author":"D Dong","year":"2016","unstructured":"Dong D, Jiang W, et al. Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin. Oncotarget. 2016;7(49):81463\u201373.","journal-title":"Oncotarget"},{"issue":"5","key":"3168_CR56","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41419-022-04960-0","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J, Zhao J, et al. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Cell Death Dis. 2022;13(5):497.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3168_CR57","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1007\/s13277-014-1670-1","volume":"35","author":"GH Sun","year":"2014","unstructured":"Sun GH, Liu YD, et al. Increased FAT10 expression is related to poor prognosis in pancreatic ductal adenocarcinoma. Tumour Biol. 2014;35(6):5167\u201371.","journal-title":"Tumour Biol"},{"issue":"18","key":"3168_CR58","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3748\/wjg.15.2228","volume":"15","author":"F Ji","year":"2009","unstructured":"Ji F, Jin X, et al. FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging. World J Gastroenterol. 2009;15(18):2228\u201333.","journal-title":"World J Gastroenterol"},{"issue":"20","key":"3168_CR59","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1101\/gad.225334.113","volume":"27","author":"JH Tsai","year":"2013","unstructured":"Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27(20):2192\u2013206.","journal-title":"Genes Dev"},{"issue":"5","key":"3168_CR60","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs AM, Mitschke J, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19(5):518\u201329.","journal-title":"Nat Cell Biol"},{"key":"3168_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216023","volume":"554","author":"X Meng","year":"2023","unstructured":"Meng X, Xiao W, et al. CircPTK2\/PABPC1\/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. Cancer Lett. 2023;554:216023.","journal-title":"Cancer Lett"},{"key":"3168_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117714","volume":"181","author":"J Yuan","year":"2024","unstructured":"Yuan J, Yang L, et al. Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers. Biomed Pharmacother. 2024;181:117714.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3168_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00944-w","volume":"7","author":"C Fan","year":"2022","unstructured":"Fan C, Wang Q, et al. OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-\u03b2 type I receptor. Signal Transduct Target Ther. 2022;7(1):126.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3168_CR64","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u201395.","journal-title":"Cell"},{"issue":"2","key":"3168_CR65","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, et al. EMT in cancer. Nat Rev Cancer. 2018;18(2):128\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"3168_CR66","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741\u201351.","journal-title":"Oncogene"},{"issue":"8","key":"3168_CR67","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, et al. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22(8):e358\u201368.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3168_CR68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers LA, Diao L, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013;19(1):279\u201390.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3168_CR69","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.15252\/emmm.201404208","volume":"6","author":"TZ Tan","year":"2014","unstructured":"Tan TZ, Miow QH, et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014;6(10):1279\u201393.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3168_CR70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13578-021-00677-3","volume":"11","author":"J Qu","year":"2021","unstructured":"Qu J, Li J, et al. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/NF-\u03baB signaling pathway. Cell Biosci. 2021;11(1):163.","journal-title":"Cell Biosci"},{"key":"3168_CR71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2021.07.001","volume":"520","author":"M Minini","year":"2021","unstructured":"Minini M, Senni A, et al. miR-125a-5p impairs the metastatic potential in breast cancer via IP(6)K1 targeting. Cancer Lett. 2021;520:48\u201356.","journal-title":"Cancer Lett"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03168-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:03:20Z","timestamp":1780301000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03168-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["3168"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03168-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Second Affiliated Hospital of Lanzhou University (2024\u00a0A-1151).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"185"}}